Glovista Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,468
Closed -$1.56M 38
2023
Q1
$1.56M Sell
6,468
-594
-8% -$146K 0.95% 19
2022
Q4
$1.85M Sell
7,062
-47
-0.7% -$12.6K 0.92% 21
2022
Q3
$1.6M Sell
7,109
-58
-0.8% -$14.1K 0.84% 23
2022
Q2
$1.74M Sell
7,167
-24
-0.3% -$5.88K 0.72% 27
2022
Q1
$1.74M Buy
+7,191
New +$1.65M 0.52% 36
2020
Q4
Sell
-916
Closed -$233K 114
2020
Q3
$233K Hold
916
0.08% 89
2020
Q2
$216K Sell
916
-1,249
-58% -$285K 0.08% 76
2020
Q1
$439K Buy
2,165
+1,249
+136% +$273K 0.23% 61
2019
Q4
$221K Buy
+916
New +$202K 0.07% 89

Other funds holding AMGN

Glovista Investments's AMGN Position: Q2 2023 in Review

Glovista Investments sold out of Amgen (AMGN) in Q2 2023, closing a stake of 6,468 shares — an estimated $1.56M sold.

Glovista Investments first reported a position in AMGN in Q4 2019 and held it in 9 quarters. The position peaked at $1.85M in Q4 2022. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Glovista Investments reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Glovista Investments sold 6,468 Amgen shares in Q2 2023, an estimated $1.56M.
  • Glovista Investments first reported a position in Amgen in Q4 2019 and held it in 9 quarters.
  • Glovista Investments's Amgen position peaked at $1.85M in Q4 2022.
  • 2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Glovista Investments's 13F filing for Q2 2023, filed 16 Aug 2023.